← FDA DRUG APPROVALS

FDA ANDA · ANDA062991

PENICILLIN G POTASSIUM

Sponsor: WATSON LABS INC

APPLICATION
ANDA062991
TYPE
ANDA
ORIGINAL APPROVAL
1988-09-13
LATEST ACTION
2000-12-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PENICILLIN G POTASSIUMDiscontinued
PENICILLIN G POTASSIUM 10,000,000 UNITS/VIAL · INJECTABLE · INJECTION
PENICILLIN G POTASSIUMDiscontinued
PENICILLIN G POTASSIUM 1,000,000 UNITS/VIAL · INJECTABLE · INJECTION
PENICILLIN G POTASSIUMDiscontinued
PENICILLIN G POTASSIUM 20,000,000 UNITS/VIAL · INJECTABLE · INJECTION
PENICILLIN G POTASSIUMDiscontinued
PENICILLIN G POTASSIUM 5,000,000 UNITS/VIAL · INJECTABLE · INJECTION

Approval history

2000-12-08Manufacturing (CMC) · Supplement 15AP
1999-05-07Manufacturing (CMC) · Supplement 14AP
1998-01-28Manufacturing (CMC) · Supplement 13AP
1995-06-28Manufacturing (CMC) · Supplement 12AP
1995-01-27Manufacturing (CMC) · Supplement 11AP
1995-01-27Manufacturing (CMC) · Supplement 10AP
1994-01-13Manufacturing (CMC) · Supplement 9AP
1993-11-17Manufacturing (CMC) · Supplement 7AP
1993-11-17Manufacturing (CMC) · Supplement 8AP
1991-01-23Manufacturing (CMC) · Supplement 5AP
1989-07-18Manufacturing (CMC) · Supplement 6AP
1989-02-03Manufacturing (CMC) · Supplement 3AP
1989-02-03Manufacturing (CMC) · Supplement 4AP
1988-12-07Manufacturing (CMC) · Supplement 2AP
1988-11-10Manufacturing (CMC) · Supplement 1AP
1988-09-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →